NCT02183051View on ClinicalTrials.gov

Study to Compare the the Analgesic Efficacy and Tolerability of Meloxicam Versus Placebo and Ibuprofen in the Treatment of Pain After Surgery of the Third Molar

PHASE2CompletedINTERVENTIONAL
Enrollment

381

Participants

Timeline

Start Date

April 30, 1998

Primary Completion Date

October 31, 1998

Conditions
Pain
Interventions
DRUG

Meloxicam 7.5 mg

DRUG

Meloxicam 3.75 mg

DRUG

Meloxicam 1.875 mg

DRUG

Ibuprofen 200 mg

DRUG

Placebo

DRUG

Meloxicam 15 mg

DRUG

Ibuprofen 400 mg

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02183051 - Study to Compare the the Analgesic Efficacy and Tolerability of Meloxicam Versus Placebo and Ibuprofen in the Treatment of Pain After Surgery of the Third Molar | Biotech Hunter | Biotech Hunter